I agree that this site is using cookies. You can find further informations here.
X
Kambhampati, Suman
98  results:
Search for persons X
?
1

DOFETILIDE UNMASKS LONG QT IN A PATIENT PRESENTING WITH ATR..:

Chelikam, Nikhila ; Kambhampati, Suman ; Katapadi, Aashish.
HeartRhythm Case Reports.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

POSTER: MM-465 In-Class Transition (iCT) from Parenteral Bo..:

Girnius, Saulius K. ; Richter, Joshua ; Lyons, Roger...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S221 , 2023
Link: https://doi.org/10.1016/..
 
?
3

MM-465 In-Class Transition (iCT) from Parenteral Bortezomib..:

Girnius, Saulius K. ; Richter, Joshua ; Lyons, Roger...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S501 , 2023
Link: https://doi.org/10.1016/..
 
?
4

PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO O..:

Girnius, Saulius K. ; Richter, Joshua ; Lyons, Roger M....
HemaSphere.  7 (2023)  S3 - p. e149880d , 2023
Link: https://doi.org/10.1097/..
 
?
5

In-class transition (iCT) of proteasome inhibitor-based the..:

Rifkin, Robert M. ; Girnius, Saulius K. ; Noga, Stephen J....
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
6

P-114 In-class transition (iCT) from parenteral bortezomib ..:

Girnius, Saulius ; Richter, Joshua ; Lyons, Roger...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S97-S98 , 2023
Link: https://doi.org/10.1016/..
 
?
7

In-Class Transition from Bortezomib-Based Therapy to IRd is..:

Rifkin, Robert M ; Costello, Caitlin L ; Birhiray, Ruemu E...
Future Oncology.  20 (2023)  3 - p. 131-143 , 2023
Link: https://doi.org/10.2217/..
 
?
8

Pevonedistat plus azacitidine vs azacitidine alone in highe..:

Adès, Lionel ; Girshova, Larisa ; Doronin, Vadim A....
Blood Advances.  6 (2022)  17 - p. 5132-5145 , 2022
Link: https://doi.org/10.1182/..
 
?
9

P-196: In-class transition (iCT) from bortezomib (V)-based ..:

Costello, Caitlin ; Birhiray, Ruemu ; Kambhampati, Suman...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S143 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Poster: MM-253 Efficacy, Safety, and Quality of Life (QoL) ..:

Manda, Sudhir ; Yimer, Habte A. ; Birhiray, Ruemu E....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S179 , 2022
Link: https://doi.org/10.1016/..
 
?
11

AML-108 SELECT-AML-1 Trial in Progress: A Phase 2 Study of ..:

Kambhampati, Suman ; Eghtedar, Alireza ; McMahon, Christine...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S213 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Oral Abstract: MDS-445 Magrolimab In Combination with Azaci..:

Sallman, David ; Malki, Monzr Al ; Asch, Adam...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S115 , 2022
Link: https://doi.org/10.1016/..
 
?
13

MM-253 Efficacy, Safety, and Quality of Life (QoL) in Patie..:

Manda, Sudhir ; Yimer, Habte A. ; Birhiray, Ruemu E....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S416-S417 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Poster: AML-108 SELECT-AML-1 Trial in Progress: A Phase 2 S..:

Kambhampati, Suman ; Eghtedar, Alireza ; McMahon, Christine...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S137 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Poster: AML-464 Tolerability and Efficacy of the First-In-C..:

Daver, Naval ; Vyas, Paresh ; Kambhampati, Suman...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S126 , 2022
Link: https://doi.org/10.1016/..
 
1-15